Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1210 Inhibitors

Inhibitors targeting KIAA1210 achieve their effects through a range of biochemical mechanisms that impede the protein's functional activity. Some inhibitors exert their effects by disrupting kinase activity, which is central to the regulation of the protein's function. These kinase inhibitors work by preventing the phosphorylation of KIAA1210 or its associated proteins, thereby blocking essential activation steps. For instance, one particular inhibitor functions by directly blocking the action of specific protein kinases that would otherwise catalyze the phosphorylation necessary for the activity of KIAA1210. Another inhibitor operates by inhibiting an upstream kinase in a signaling cascade, which is crucial for the subsequent activation of KIAA1210; without this initial phosphorylation event, the downstream proteins, including KIAA1210, remain inactive. Other inhibitors target cellular growth and proliferation pathways, such as those regulated by mTOR, and by blocking these pathways, they indirectly lead to the inhibition of KIAA1210 activity by depriving it of the signals that would typically promote its function.

Additional inhibitors focus on stress response pathways, such as those mediated by p38 MAP kinase or JNK, where the inhibition of these kinases results in the attenuation of the signaling processes that would normally involve KIAA1210. The inhibition of tyrosine kinases by certain compounds also plays a critical role, as it disrupts signaling that may be vital for the functional activity of KIAA1210. Moreover, some inhibitors interfere with proteostasis by preventing proteasome function, leading to the accumulation of ubiquitinated proteins that may include regulatory elements governing KIAA1210 activity. By increasing the levels of these regulatory proteins, the inhibitors effectively cause a decrease in KIAA1210 activity. Another subset of inhibitors acts by obstructing the AKT pathway, which is a key conduit for signaling that, when inhibited, results in reduced activity of proteins like KIAA1210 that may be regulated by this pathway.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that, by inhibiting multiple kinases which may interact with or phosphorylate KIAA1210, could lead to the inhibition of KIAA1210's kinase-related functions.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A phosphoinositide 3-kinases (PI3K) inhibitor, which would prevent the phosphorylation of downstream targets that could include KIAA1210, thereby inhibiting its activation and signaling functions.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can suppress the mTOR pathway, reducing the phosphorylation and activation of KIAA1210 if it is a downstream target in this pathway.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that changes the chromatin structure and could decrease the expression of certain genes, including KIAA1210, thus reducing its protein levels and functional activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A specific inhibitor of MEK, which could decrease the MAPK/ERK pathway activity, leading to reduced activity of KIAA1210 if it is involved in this signaling cascade.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that may reduce the activity of proteins regulated by the p38 MAPK pathway, including KIAA1210 if it is a substrate or associated with this pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK) which can decrease the activity of proteins regulated by JNK signaling, affecting KIAA1210's activity if it is associated with this pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A broad-spectrum PI3K inhibitor, which could lead to a decrease in the phosphorylation of proteins involved in the PI3K/Akt pathway, affecting KIAA1210 if it is regulated by this signaling route.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK1/2, which are upstream regulators of the ERK pathway, can inhibit the activation of ERK and affect the activity of KIAA1210 if it is implicated in ERK pathway signaling.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

A tyrosine kinase inhibitor that could inhibit the kinase activity on proteins that are involved in multiple signaling pathways, reducing the functional activity of KIAA1210 if it is a kinase substrate.